JPMorgan’s Chris Schott says there are “far more paths to upside” than to declines for shares of the pharmaceutical company.

source https://finance.yahoo.com/m/d1d0d615-90fb-31ea-a3e1-ff8533c4dfd6/bristol-myers-stock-is.html?.tsrc=rss